This inventor holds 1 USPTO granted patent. Top assignee: The Rockefeller University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Weiwei Wang: Innovator in Pharmacological Assays
Introduction
Weiwei Wang is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmacology, particularly in the development of assays for hERG channel proteins. Her innovative work has implications for cardiac health and drug development.
Latest Patents
Weiwei Wang holds a patent for "Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents." This invention provides methods and compositions related to an assay for hERG channel protein sensitivity to small molecule pharmacological agents. The patent includes an engineered hERG channel protein and a method for identifying small molecule pharmacological agents that interfere with the repolarization of cardiac cells. She has 1 patent to her name.
Career Highlights
Weiwei Wang is affiliated with The Rockefeller University, where she conducts her research. Her work is at the intersection of biology and pharmacology, focusing on improving drug safety and efficacy.
Collaborations
Some of her notable coworkers include Roderick MacKinnon and Zhenwei Su. Their collaborative efforts contribute to advancing research in the field of pharmacology.
Conclusion
Weiwei Wang's innovative contributions to pharmacological assays highlight her role as a key inventor in the field. Her work continues to influence drug development and cardiac health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile